Human Genome Sciences Newswire

Comprehensive Real-Time News Feed for Human Genome Sciences.

Results 1 - 20 of 23 in Human Genome Sciences

  1. FDAnews Announces Choosing the Best Device Sample Size for...Read the original story

    Monday Aug 18 | PRWeb

    ... starting Statistical Outsourcing Services, he was the Senior Manager Biostatistics, Non-clinical, at Human Genome Sciences in Rockville, MD. Prior to joining HGS, he was a senior associate at PricewaterhouseCoopers specializing in the pharmaceutical ...

    Comment?

  2. On the Move: Personnel moves in the local life sciences industryRead the original story w/Photo

    Friday Aug 15 | Business Journal

    ... will also join the board of directors. He previously served as executive vice president and CFO of Human Genome Sciences (Nasdaq: HGSI) during the approval and launch of Benlysta, a biologic treatment for lupus, up to the company's acquisition by ...

    Comment?

  3. News from Abroad: The Regretful Patentee -- The Re-Emergence of File...Read the original story

    Wednesday Aug 13 | JD Supra

    ... made little use of file wrappers in subsequent cases with Sir Robin Jacob observing in Eli Lilly v Human Genome Sciences [4] that he was not confident it was legitimate to do so even though the UK courts had yet to decide the matter conclusively. ...

    Comment?

  4. Inotek Appoints CEORead the original story

    Wednesday Aug 13 | Contract Pharma Breaking News

    ... Prior to joining the company, he served as executive vice president and chief financial officer of Human Genome Sciences (acquired by GlaxoSmithKline in 2012). Before joining the management team of Human Genome Sciences, he served on the company's ...

    Comment?

  5. Inotek Pharmaceuticals Names David P. Southwell as President and Chief Executive OfficerRead the original story

    Wednesday Aug 13 | Business Wire

    ... to joining Inotek, Mr. Southwell served as Executive Vice President and Chief Financial Officer of Human Genome Sciences (NASDAQ:HGSI) during the approval and launch of BenlystaA , a novel biologic treatment for lupus, up to the company's ...

    Comment?

  6. Inotek Pharmaceuticals Corporation Brings In A New President And CEORead the original story

    Wednesday Aug 13 | BioSpace

    ... to joining Inotek, Mr. Southwell served as Executive Vice President and Chief Financial Officer of Human Genome Sciences (NASDAQ:HGSI) during the approval and launch of BenlystaA , a novel biologic treatment for lupus, up to the company's ...

    Comment?

  7. Horizon Pharma's (HZNP) CEO Tim Walbert on Q2 2014 Results - Earnings Call TranscriptRead the original story

    Thursday Aug 7 | Seeking Alpha

    ... to our Board of Directors, most recently Tom was Director, President and Chief Executive Officer of Human Genome Sciences from 2004 until its acquisition by Glaxo in 2012. In addition we announced the appointment of Paul Hoelscher to Executive Vice ...

    Comment?

  8. James Davis , Biotechnology Consultant, Elected Chair Of The...Read the original story

    Jul 17, 2014 | BioSpace

    ... with blood cancers. Davis is the former executive vice president, general counsel and secretary of Human Genome Sciences, Inc., a biopharmaceutical company that pioneered new treatments in the areas of auto-immune diseases, cancer, and bioterrorism. ...

    Comment?

  9. Pershing Square Proposes Independent Slate For Allergan Board of DirectorsRead the original story

    Jul 7, 2014 | Business Wire

    ... Ingredients Pte. Ltd., from 1991 through 1993. She has also served on the Board of Directors of Human Genome Sciences Inc. (NASDAQ: HGSI), HealthSouth Corporation (NYSE: HLS), Vonage Holdings Inc. (NYSE: VG), Towers Watson & Co. (NYSE: TW), Reynolds ...

    Comment?

  10. Johnson joins Louisville Men's Basketball staff as assistant coachRead the original story w/Photo

    Apr 23, 2014 | WHAS11

    ... was a Benjamin Banneker Scholarship recipient. He worked as a protein chemist/molecular biologist at Human Genome Sciences in Rockville, Md. after graduation. A native of Oxon Hill, Md., Johnson and his wife, Doreen, have two sons, Amare (11) and ...

    Comment?

  11. Johnson joins Louisville Men's Basketball staff as assistant coachRead the original story

    Apr 23, 2014 | WHAS11

    ... was a Benjamin Banneker Scholarship recipient. He worked as a protein chemist/molecular biologist at Human Genome Sciences in Rockville, Md. after graduation. A native of Oxon Hill, Md., Johnson and his wife, Doreen, have two sons, Amare (11) and ...

    Comment?

  12. Horizon Pharma Announces The Appointment Of H. Thomas Watkins To Its Board Of DirectorsRead the original story

    Apr 17, 2014 | BioSpace

    Horizon Pharma, Inc. today announced the appointment of H. Thomas Watkins, former director, president and chief executive officer of Human Genome Sciences, to its board of directors.

    Comment?

  13. Horizon Pharma Announces the Appointment of H. Thomas Watkins to Its Board of DirectorsRead the original story

    Apr 17, 2014 | Freshnews

    ... the appointment of H. Thomas Watkins, former director, president and chief executive officer of Human Genome Sciences, to its board of directors. Additionally, Jean-Francois Formela, M.D. has resigned from the Horizon board of directors. "Tom brings ...

    Comment?

  14. Scheer Partners, Inc. Hired By To Lease 9410 Key West Avenue In RockvilleRead the original story

    Apr 16, 2014 | BioSpace

    ... stellar biotechnology companies for more than 20 years. In 1994 the building was originally leased to Human Genome Sciences, Inc. (HGSI). In 2006, HGSI spun out CoGenesys, which developed biological drugs to help cancer patients undergoing ...

    Comment?

  15. FDAnews Announces - Sample Size Considerations for Verification and ...Read the original story

    Apr 16, 2014 | PRWeb

    ... starting Statistical Outsourcing Services, he was the Senior Manager Biostatistics, Non-clinical, at Human Genome Sciences in Rockville, MD. Prior to joining HGS, he was a senior associate at PricewaterhouseCoopers specializing in the pharmaceutical ...

    Comment?

  16. Bad news for GlaxoSmithKline's darapladib, a drug key to Human Genome Sciences buyoutRead the original story

    Mar 31, 2014 | Business Journal

    GlaxoSmithKline this weekend illustrated disappointing results of a late-stage trial for heart drug darapladib, one of the three major assets the British pharma company scooped up in its $3 billion acquisition of Rockville's Human Genome Sciences two years ago.

    Comment?

  17. Bad news for GlaxoSmithKline's darapladib, a drug key to Human Genome Sciences buyoutRead the original story

    Mar 31, 2014 | Business Journal

    GlaxoSmithKline this weekend illustrated disappointing results of a late-stage trial for heart drug darapladib, one of the three major assets the British pharma company scooped up in its $3 billion acquisition of Rockville's Human Genome Sciences two years ago.

    Comment?

  18. GSK Ceo says success of heart drug 'an open question'Read the original story

    Mar 31, 2014 | Reuters

    ... Gaining full control of darapladib was one of the reasons behind GSK's $3.6 billion acquisition of Human Genome Sciences in 2012 and the company has invested heavily in the two clinical trials into the drug, which involved nearly 30,000 patients. We ...

    Comment?

  19. Study shows Glaxo heart drug which failed trial has potential benefitRead the original story w/Photo

    Mar 30, 2014 | West Australian

    ... as gaining full control of darapladib was one of the reasons behind its $3.6 billion acquisition of Human Genome Sciences in 2012. Human Genome had rejected an earlier $2.6 billion offer, on the grounds that Glaxo was underestimating the blockbuster ...

    Comment?

  20. ComplianceOnline Seminar on Statistical Analysis for Product Development Comes to WisconsinRead the original story

    Mar 28, 2014 | PRWeb

    ... collection, analysis and reporting. Mr. Walfish was the Senior Manager Biostatistics, Non-clinical at Human Genome Sciences in Rockville MD. During the two day interactive seminar, Mr. Walfish will explain how to improve process output ...

    Comment?